RECORDATI INDUSTRIA CHIMICA (REC.MI) Stock Price & Overview

BIT:RECIT0003828271

Current stock price

43.92 EUR
-0.74 (-1.66%)
Last:

The current stock price of REC.MI is 43.92 EUR. Today REC.MI is down by -1.66%. In the past month the price decreased by -7.31%. In the past year, price decreased by -16.45%.

REC.MI Key Statistics

52-Week Range43.98 - 55.35
Current REC.MI stock price positioned within its 52-week range.
1-Month Range44.3 - 49.02
Current REC.MI stock price positioned within its 1-month range.
Market Cap
9.185B
P/E
22.41
Fwd P/E
15.32
EPS (TTM)
1.96
Dividend Yield
2.73%

REC.MI Stock Performance

Today
-1.66%
1 Week
-3.38%
1 Month
-7.31%
3 Months
-7.23%
Longer-term
6 Months -15.42%
1 Year -16.45%
2 Years -12.84%
3 Years +14.63%
5 Years -2.64%
10 Years N/A

REC.MI Stock Chart

RECORDATI INDUSTRIA CHIMICA / REC Daily stock chart

REC.MI Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to REC.MI. When comparing the yearly performance of all stocks, REC.MI is a bad performer in the overall market: 80.4% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

REC.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to REC.MI. REC.MI has a medium profitability rating, but doesn't score so well on its financial health evaluation.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

REC.MI Earnings

Next Earnings DateMay 12, 2026
Last Earnings DateFeb 17, 2026
PeriodQ3 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

REC.MI Forecast & Estimates

15 analysts have analysed REC.MI and the average price target is 59.52 EUR. This implies a price increase of 35.51% is expected in the next year compared to the current price of 43.92.

For the next year, analysts expect an EPS growth of 4.67% and a revenue growth 12.66% for REC.MI


Analysts
Analysts78.67
Price Target59.52 (35.52%)
EPS Next Y4.67%
Revenue Next Year12.66%

REC.MI Groups

Sector & Classification

REC.MI Financial Highlights

Over the last trailing twelve months REC.MI reported a non-GAAP Earnings per Share(EPS) of 1.96. The EPS increased by 0.34% compared to the year before.


Income Statements
Revenue(TTM)2.55B
Net Income(TTM)404.39M
Industry RankSector Rank
PM (TTM) 15.83%
ROA 7.63%
ROE 20.98%
Debt/Equity 1.14
Chartmill High Growth Momentum
EPS Q2Q%-2.03%
Sales Q2Q%13.44%
EPS 1Y (TTM)0.34%
Revenue 1Y (TTM)12.58%

REC.MI Ownership

Ownership
Inst Owners31.58%
Shares209.13M
Float106.65M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About REC.MI

Company Profile

REC logo image Recordati SpA engages in the research, development, manufacture, and marketing of pharmaceuticals. The company is headquartered in Milan, Milano and currently employs 4,583 full-time employees. The company promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The firm is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. The company operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The firm owns and operates through Natural Point srl also in the food supplement sector.

Company Info

IPO: 1984-01-01

RECORDATI INDUSTRIA CHIMICA

Via Matteo Civitali, 1

Milan MILANO IT

Employees: 4539

REC Company Website

REC Investor Relations

Phone: 3902487871

RECORDATI INDUSTRIA CHIMICA / REC.MI FAQ

What does RECORDATI INDUSTRIA CHIMICA do?

Recordati SpA engages in the research, development, manufacture, and marketing of pharmaceuticals. The company is headquartered in Milan, Milano and currently employs 4,583 full-time employees. The company promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The firm is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. The company operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The firm owns and operates through Natural Point srl also in the food supplement sector.


What is the stock price of RECORDATI INDUSTRIA CHIMICA today?

The current stock price of REC.MI is 43.92 EUR. The price decreased by -1.66% in the last trading session.


Does RECORDATI INDUSTRIA CHIMICA pay dividends?

RECORDATI INDUSTRIA CHIMICA (REC.MI) has a dividend yield of 2.73%. The yearly dividend amount is currently 1.23.


What is the ChartMill technical and fundamental rating of REC stock?

REC.MI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


On which exchange is REC.MI stock listed?

REC.MI stock is listed on the Euronext Milan exchange.


What is the GICS sector and industry of REC stock?

RECORDATI INDUSTRIA CHIMICA (REC.MI) operates in the Health Care sector and the Pharmaceuticals industry.


What is the ownership structure of RECORDATI INDUSTRIA CHIMICA (REC.MI)?

You can find the ownership structure of RECORDATI INDUSTRIA CHIMICA (REC.MI) on the Ownership tab.